Journal of Vascular and Interventional Radiology
Volume 21, Issue 3 , Pages 387-391 , March 2010

Acquired Peripheral Arteriovenous Malformations in Patients with Venous Thrombosis: Report of Two Cases

Received 7 July 2008 ,Revised 21 September 2009 ,Accepted 4 October 2009.

References 

  1. Yakes WF, Haas DK, Parker SH, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology. 1989;170:1059–1066
  2. Fournier D, Rodesch G, Terbrugge K, Flodmark O, Lasjaunias P. Acquired mural (dural) arteriovenous shunts of the vein of Galen: report of 4 cases. Neuroradiology. 1991;33:52–55
  3. Rubin JM, Xie H, Kim K, et al. Sonographic elasticity imaging of acute and chronic deep venous thrombosis in humans. J Ultrasound Med. 2006;25:1179–1186
  4. Kaufman JA, Lee MJ. Vascular and interventional radiology. 1st ed.. St. Louis: Mosby; 2004;
  5. Allison DJ, Kennedy A. ABC of vascular diseases (Peripheral arteriovenous malformations). Br Med J. 1991;303:1191–1194
  6. Ozawa T, Miyasaka Y, Tanaka R, Kurata A, Fujii K. Dural-pial arteriovenous malformation after sinus thrombosis. Stroke. 1998;29:1721–1724
  7. Phatouros CC, Halbach VV, Dowd CF, et al. Acquired pial arteriovenous fistula following cerebral vein thrombosis. Stroke. 1999;30:2487–2490
  8. Bleiziffer O, Horch RE, Hammon M, et al. T17b murine embryonal endothelial progenitor cells can be induced towards both proliferation and differentiation in a fibrin matrix. J Cell Mol Med. 2009;13:926–935
  9. Polykandriotis E, Arkudas A, Horch RE, Kneser U. To matrigel or not to matrigel. Am J Pathol. 2008;172:1441
  10. Ryu JH, Kim IK, Cho SW, et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances revascularization in infracted myocardium. Biomaterials. 2005;26:319–326
  11. Blinc A, Golli T, Vodnik AC, Zver S. Concurrent thalidomide and radiation therapy for extensive arterio-venous malformations. Thromb Haemost. 2008;99:235–237
  12. Kubis N, Levy BI. Understanding angiogenesis: a clue for understanding vascular malformations. J Neuroradiol. 2004;31:365–368
  13. Patan S, Munn LL, Tanda S, Roberge S, Jain RK, Jones RC. Vascular morphogenesis and remodeling in a model of tissue repair: blood vessel formation and growth in the ovarian pedicle after ovariectomy. Circ Res. 2001;89:723–731
  14. Kachlik D, Stingl J, Sosna B, et al. Morphological features of vasa vasorum in pathologically changed human great saphenous vein and its tributaries. Vasa. 2008;37:127–136
  15. Terada T, Higashida RT, Halbach VV, et al. Development of acquired arteriovenous fistulas in rats due to venous hypertension. J Neurosurg. 1994;80:884–889
  16. Rosendorff A, Dorfman DM. Activated protein C resistance and factor V Leiden: a review. Arch Pathol Lab Med. 2007;131:866–871
  17. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503–1506
  18. Kraus JA, Stuper BK, Berlit P. Association of resistance to activated protein C and dural arteriovenous fistulas. J Neurol. 1998;245:731–733
  19. Do YS, Yakes WF, Shin SW, et al. Ethanol embolization of arteriovenous malformations: interim results. Radiology. 2005;235:674–682
  20. Lee BB, Kim DI, Huh S, et al. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg. 2001;33:764–772

 None of the authors have identified a conflict of interest.

PII: S1051-0443(09)01099-9

doi: 10.1016/j.jvir.2009.10.035

Journal of Vascular and Interventional Radiology
Volume 21, Issue 3 , Pages 387-391 , March 2010